AmerisourceBergen announces expected name change in 2023

Conshohocken-based AmerisourceBergen, a global pharmaceutical solutions organization, recently announced its plans to change its name to Cencora during the second half of the year.

“Over time, we have established ourselves as a trusted industry partner that prioritizes innovation, advocates for patient access, and advances strategic partnerships across the global pharmaceutical supply chain,” said Steven H. Collis, AmerisourceBergen chairman, president and CEO. “To further bolster our position, we must continue to adapt and evolve within our dynamic industry as we pursue the goal of enhancing health outcomes. Building a unified brand is fundamental to our identity as a global healthcare company. We believe our new name better reflects who we are today and our impact across pharmaceutical care.”

The change represents the unified presence of customers and employees worldwide. The shared identity will create a more inclusive experience for employees, a stronger employer brand to attract talent, and increase employee loyalty, retention, and performance, the company said.

In addition, the change is aligned with the organization’s growth strategy and emphasis on innovation.

As Cencora, the company will continue to grow its pharma and biopharma services platform to support pharmaceutical innovation and access, invest in, and focus on its core pharmaceutical distribution business.